Paul Tudor Jones Mirum Pharmaceuticals, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 23,966 shares of MIRM stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,966Holding current value
$1.11 Million% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding MIRM
# of Institutions
210Shares Held
53.7MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$304 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$212 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$150 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$129 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$121 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.7B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...